Page last updated: 2024-10-26

valproic acid and Pancreatic Diseases

valproic acid has been researched along with Pancreatic Diseases in 2 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Pancreatic Diseases: Pathological processes of the PANCREAS.

Research Excerpts

ExcerptRelevanceReference
" Clinical data on epilepsy, characteristics of VPA treatment, risk factors for VHT, laboratory data on liver and pancreas functions, and adverse effects were collected."1.48Variants p.Q1236H and p.E1143G in mitochondrial DNA polymerase gamma POLG1 are not associated with increased risk for valproate-induced hepatotoxicity or pancreatic toxicity: A retrospective cohort study of patients with epilepsy. ( Ansakorpi, H; Eriksson, K; Haapala, P; Haataja, L; Hinttala, R; Hynynen, J; Jyrkilä, A; Kälviäinen, R; Kärppä, M; Komulainen-Ebrahim, J; Lähdetie, J; Majamaa, K; Mäkitalo, A; Myllynen, P; Pokka, T; Pylvänen, L; Rantala, H; Sokka, A; Uusimaa, J; Vieira, P; Ylikotila, P, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hynynen, J1
Pokka, T1
Komulainen-Ebrahim, J1
Myllynen, P1
Kärppä, M1
Pylvänen, L1
Kälviäinen, R1
Sokka, A1
Jyrkilä, A1
Lähdetie, J1
Haataja, L1
Mäkitalo, A1
Ylikotila, P1
Eriksson, K1
Haapala, P1
Ansakorpi, H1
Hinttala, R1
Vieira, P1
Majamaa, K1
Rantala, H1
Uusimaa, J1
Jimenez-Rodriguezvila, M1
Caro-Patón, A1
Conde, M1
Dueñas-Laita, A1
Martin-Lorente, JL1
Fernandez Perez de Villalain, MJ1
Gonzalez Martinez de Zarate, JL1
Marañon, A1

Other Studies

2 other studies available for valproic acid and Pancreatic Diseases

ArticleYear
Variants p.Q1236H and p.E1143G in mitochondrial DNA polymerase gamma POLG1 are not associated with increased risk for valproate-induced hepatotoxicity or pancreatic toxicity: A retrospective cohort study of patients with epilepsy.
    Epilepsia, 2018, Volume: 59, Issue:11

    Topics: Adolescent; Adult; Alanine Transaminase; Anticonvulsants; Aspartate Aminotransferases; Chemical and

2018
Side-effects of sodium valproate, mainly related to its hepatic and pancreatic toxicity.
    International journal of clinical pharmacology research, 1986, Volume: 6, Issue:3

    Topics: Adolescent; Adult; Aged; Amylases; Body Weight; Chemical and Drug Induced Liver Injury; Child; Child

1986